S. Neelakantham

发表

Pharmacokinetic drug–drug interaction assessment of LCZ696 (an angiotensin receptor neprilysin inhibitor) with omeprazole, metformin or levonorgestrel‐ethinyl estradiol in healthy subjects

W. Zhou, Lu Gan, Xuemin Jiang, 2016, Clinical pharmacology in drug development.

Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of Intravenous Siponimod: A Randomized, Open-label Study in Healthy Subjects.

E. Legangneux, S. Neelakantham, Swati Dumitras, 2020, Clinical therapeutics.

Siponimod pharmacokinetics, safety, and tolerability in combination with rifampin, a CYP2C9/3A4 inducer, in healthy subjects

E. Legangneux, S. Neelakantham, Swati Dumitras, 2018, European Journal of Clinical Pharmacology.

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Novel Non–Bile Acid FXR Agonist Tropifexor (LJN452) in Healthy Volunteers

B. Laffitte, Lu Gan, S. Neelakantham, 2019, Clinical pharmacology in drug development.

Pharmacokinetics, Safety, and Tolerability of Fevipiprant (QAW039), a Novel CRTh2 Receptor Antagonist: Results From 2 Randomized, Phase 1, Placebo‐Controlled Studies in Healthy Volunteers

S. Neelakantham, V. Erpenbeck, M. Larbig, 2016, Clinical pharmacology in drug development.

Abuse and dependence potential of sphingosine-1-phosphate (S1P) receptor modulators used in the treatment of multiple sclerosis: a review of literature and public data

S. Neelakantham, C. Kolly, K. Shakeri-Nejad, 2021, Psychopharmacology.

Siponimod pharmacokinetics, safety, and tolerability in combination with the potent CYP3A4 inhibitor itraconazole in healthy subjects with different CYP2C9 genotypes

S. Neelakantham, Andrea J Feller, Swati Dumitras, 2019, European Journal of Clinical Pharmacology.

Differential effects of vildagliptin and glimepiride on glucose fluctuations in patients with type 2 diabetes mellitus assessed using continuous glucose monitoring

T. Forst, S. Neelakantham, K. Kulmatycki, 2013, Diabetes, obesity & metabolism.

Pharmacokinetics, safety, and tolerability of siponimod (BAF312) in subjects with severe renal impairment: A single-dose, open-label, parallel-group study .

E. Legangneux, S. Neelakantham, S. Kalluri, 2017, International journal of clinical pharmacology and therapeutics.

Bioavailability of valsartan oral dosage forms

A. Mendonza, S. Neelakantham, G. Sunkara, 2014, Clinical pharmacology in drug development.

Bimagrumab improves body composition and insulin sensitivity in insulin‐resistant individuals

M. Buchsbaum, R. Roubenoff, L. Morrow, 2018, Diabetes, obesity & metabolism.

Early assessment of safety and efficacy of tropifexor, a potent non bile-acid FXR agonist, in patients with primary biliary cholangitis: An interim analysis of an ongoing phase 2 study

H. Wedemeyer, G. Hirschfield, C. Schramm, 2018 .

Effect of Pradigastat, a Diacylglycerol Acyltransferase 1 Inhibitor, on the QTcF Interval in Humans

S. Neelakantham, K. Kulmatycki, C. Meyers, 2016, Clinical pharmacology in drug development.

Assessment of pharmacokinetic drug‐drug interaction between pradigastat and atazanavir or probenecid

Imad Hanna, A. Mendonza, S. Neelakantham, 2016, Journal of clinical pharmacology.

Pharmacokinetic and pharmacodynamic drug–drug interaction assessment between pradigastat and digoxin or warfarin

S. Neelakantham, S. Rebello, G. Sunkara, 2014, Journal of clinical pharmacology.

Siponimod pharmacokinetics, safety, and tolerability in combination with rifampin, a CYP2C9/3A4 inducer, in healthy subjects

E. Legangneux, S. Neelakantham, Swati Dumitras, 2018, European Journal of Clinical Pharmacology.

Siponimod pharmacokinetics, safety, and tolerability in combination with the potent CYP3A4 inhibitor itraconazole in healthy subjects with different CYP2C9 genotypes

S. Neelakantham, Andrea J Feller, Swati Dumitras, 2019, European Journal of Clinical Pharmacology.

Effect of mavoglurant (AFQ056), a selective mGluR5 antagonist, on the pharmacokinetics of a combined oral contraceptive containing ethinyl estradiol and levonorgestrel in healthy women.

R. Woessner, E. Legangneux, S. Neelakantham, 2015, International journal of clinical pharmacology and therapeutics.